OSU-03012 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "OSU-03012" in English language version.

refsWebsite

Global rank English rank

37nih.gov

4^th place

19doi.org

2^nd place

2semanticscholar.org

11^th place

8^th place

1web.archive.org

1^st place

1freepatentsonline.com

5,449^th place

3,875^th place

1reuters.com

49^th place

47^th place

doi.org

Booth, L; Cruickshanks, N; Ridder, T; Chen, CS; Grant, S; Dent, P (Dec 2012). "OSU-03012 interacts with lapatinib to kill brain cancer cells". Cancer Biology and Therapy. 13 (14): 1501–11. doi:10.4161/cbt.22275. PMC 3542242. PMID 22990204.
Ma, Y; McCarty, SK; Kapuriya, NP; Brendel, VJ; Wang, C; Zhang, X; Jarjoura, D; Saji, M; Chen, CS; Ringel, MD (Aug 2013). "Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration". Journal of Clinical Endocrinology and Metabolism. 98 (8): E1314–22. doi:10.1210/jc.2012-3937. PMC 3733855. PMID 23709653.
Booth, L; Roberts, JL; Cruickshanks, N; Grant, S; Poklepovic, A; Dent, P (Oct 2014). "Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs". Molecular Cancer Therapeutics. 13 (10): 2384–98. doi:10.1158/1535-7163.MCT-14-0172. PMC 4185238. PMID 25103559.
Liu, J; Qin, CK; Lv, W; Zhao, Q; Qin, CY (2013). "OSU-03012, a non-Cox inhibiting celecoxib derivative, induces apoptosis of human esophageal carcinoma cells through a p53/Bax/cytochrome c/caspase-9-dependent pathway" (PDF). Anticancer Drugs. 24 (7): 690–8. doi:10.1097/CAD.0b013e328362469f. PMID 23652278. S2CID 6028415. Archived from the original (PDF) on 2019-03-08.
Koselny, K; Green, J; Favazzo, L; Glazier, VE; DiDone, L; Ransford, S; Krysan, DJ (8 Apr 2016). "Antitumor/Antifungal Celecoxib Derivative AR-12 is a Non-Nucleoside Inhibitor of the ANL-Family Adenylating Enzyme Acetyl CoA Synthetase". ACS Infect Dis. 2 (4): 268–280. doi:10.1021/acsinfecdis.5b00134. PMC 4828684. PMID 27088128.
Koselny, K; Green, J; DiDone, L; Halterman, JP; Fothergill, AW; Wiederhold, NP; Patterson, TF; Cushion, MT; Rappelye, C; Wellington, M; Krysan, DJ (2016). "The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis". Antimicrob Agents Chemother. 60 (12): 7115–7127. doi:10.1128/AAC.01061-16. PMC 5118990. PMID 27645246.
Koselny, K; Green, J; DiDone, L; Halterman, JP; Fothergill, AW; Wiederhold, NP; Patterson, TF; Cushion, MT; Rappelye, C; Wellington, M; Krysan, DJ (2016). "The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis". Antimicrob Agents Chemother. 60 (12): 7115–7127. doi:10.1128/AAC.01061-16. PMC 5118990. PMID 27645246.
Collier, MA; Peine, KJ; Gautum, S; Oghumu, S; Varikuti, S; Borteh, H; Papenfuss, TL; Satoskar, AR; Bachelder, EM; Ainslie, KM (Feb 29, 2016). "Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles". International Journal of Pharmaceutics. 499 (1–2): 186–94. doi:10.1016/j.ijpharm.2016.01.004. PMC 5730989. PMID 26768723.
Chiu, HC; Kulp, SK; Soni, S; Wang, D; Gunn, JS; Schlesinger, LS; Chen, CS (Dec 2009). "Eradication of intracellular Salmonella enterica serovar Typhimurium with a small-molecule, host cell-directed agent". Antimicrob Agents Chemother. 53 (12): 5236–5244. doi:10.1128/aac.00555-09. PMC 2786354. PMID 19805568.
Hoang, KV; Borteh, HM; Rajaram, MV; Peine, KJ; Curry, H; Collier, MA; Homsy, ML; Bachelder, EM; Gunn, JS; Schlesinger, LS; Ainslie, KM (Dec 2014). "Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection". Int J Pharm. 477 (1–2): 334–343. doi:10.1016/j.ijpharm.2014.10.022. PMC 4267924. PMID 25447826.
Chiu, HC; Soni, S; Kulp, SK; Curry, H; Wang, D; Gunn, JS; Schlesinger, LS; Chen, CS (Dec 2009). "Eradication of intracellular Francisella tularensis in THP-1 human macrophages with a novel autophagy inducing agent". J Biomed Sci. 16 (1): 110. doi:10.1186/1423-0127-16-110. PMC 2801672. PMID 20003180.
Hoang, KV; Curry, H; Collier, MA; Borteh, H; Bachelder, EM; Schlesinger, LS; Gunn, JS; Ainslie, KM (Mar 25, 2016). "Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge". Antimicrob Agents Chemother. 60 (4): 2052–62. doi:10.1128/AAC.02228-15. PMC 4808193. PMID 26787696.
Lo, JH; Kulp, SK; Chen, CS; Chiu, HC (Dec 2014). "Sensitization of intracellular Salmonella enterica serovar Typhimurium to aminoglycosides in vitro and in vivo by a host-targeted antimicrobial agent". Antimicrob Agents Chemother. 58 (12): 7375–82. doi:10.1128/AAC.03778-14. PMC 4249550. PMID 25267669.
Dent, Paul; et al. (2014). "GRP78 / BiP / HSPA5 / Dna K is a universal therapeutic target for human disease". Journal of Cellular Physiology. 230 (7): 1661–1676. doi:10.1002/jcp.24919. PMC 4402027. PMID 25546329.
Collier, MA; Gallovic, MD; Peine, KJ; Duong, AD; Bachelder, EM; Gunn, JS; Schlesingr, LS; Ainslie, KM (Nov 2013). "Delivery of host cell-directed therapeutics for intracellular pathogen clearance". Expert Rev Anti Infect Ther. 11 (11): 1225–1235. doi:10.1586/14787210.2013.845524. PMC 4070714. PMID 24134600.
Chiu, HC; Kulp, SK; Soni, S; Wang, D; Gunn, JS; Schlesinger, LS; Chen, CS (Dec 2009). "Eradication of intracellular Salmonella enterica serovar Typhimurium with a small-molecule, host cell-directed agent". Antimicrob Agents Chemother. 53 (12): 5236–5244. doi:10.1128/aac.00555-09. PMC 2786354. PMID 19805568.
Hoang, KV; Borteh, HM; Rajaram, MV; Peine, KJ; Curry, H; Collier, MA; Homsy, ML; Bachelder, EM; Gunn, JS; Schlesinger, LS; Ainslie, KM (Dec 2014). "Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection". Int J Pharm. 477 (1–2): 334–343. doi:10.1016/j.ijpharm.2014.10.022. PMC 4267924. PMID 25447826.
Hoang, KV; Borteh, HM; Rajaram, MV; Peine, KJ; Curry, H; Collier, MA; Homsy, ML; Bachelder, EM; Gunn, JS; Schlesinger, LS; Ainslie, KM (Dec 2014). "Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection". Int J Pharm. 477 (1–2): 334–343. doi:10.1016/j.ijpharm.2014.10.022. PMC 4267924. PMID 25447826.
Hoang, KV; Curry, H; Collier, MA; Borteh, H; Bachelder, EM; Schlesinger, LS; Gunn, JS; Ainslie, KM (Mar 25, 2016). "Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge". Antimicrob Agents Chemother. 60 (4): 2052–62. doi:10.1128/AAC.02228-15. PMC 4808193. PMID 26787696.

freepatentsonline.com

Ainslie; et al. "COMPOSITIONS AND METHODS FOR INHIBITING LEISHMANIA". Free Patents Online.

nih.gov

pubmed.ncbi.nlm.nih.gov

Booth, L; Cruickshanks, N; Ridder, T; Chen, CS; Grant, S; Dent, P (Dec 2012). "OSU-03012 interacts with lapatinib to kill brain cancer cells". Cancer Biology and Therapy. 13 (14): 1501–11. doi:10.4161/cbt.22275. PMC 3542242. PMID 22990204.
Ma, Y; McCarty, SK; Kapuriya, NP; Brendel, VJ; Wang, C; Zhang, X; Jarjoura, D; Saji, M; Chen, CS; Ringel, MD (Aug 2013). "Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration". Journal of Clinical Endocrinology and Metabolism. 98 (8): E1314–22. doi:10.1210/jc.2012-3937. PMC 3733855. PMID 23709653.
Booth, L; Roberts, JL; Cruickshanks, N; Grant, S; Poklepovic, A; Dent, P (Oct 2014). "Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs". Molecular Cancer Therapeutics. 13 (10): 2384–98. doi:10.1158/1535-7163.MCT-14-0172. PMC 4185238. PMID 25103559.
Liu, J; Qin, CK; Lv, W; Zhao, Q; Qin, CY (2013). "OSU-03012, a non-Cox inhibiting celecoxib derivative, induces apoptosis of human esophageal carcinoma cells through a p53/Bax/cytochrome c/caspase-9-dependent pathway" (PDF). Anticancer Drugs. 24 (7): 690–8. doi:10.1097/CAD.0b013e328362469f. PMID 23652278. S2CID 6028415. Archived from the original (PDF) on 2019-03-08.
Koselny, K; Green, J; Favazzo, L; Glazier, VE; DiDone, L; Ransford, S; Krysan, DJ (8 Apr 2016). "Antitumor/Antifungal Celecoxib Derivative AR-12 is a Non-Nucleoside Inhibitor of the ANL-Family Adenylating Enzyme Acetyl CoA Synthetase". ACS Infect Dis. 2 (4): 268–280. doi:10.1021/acsinfecdis.5b00134. PMC 4828684. PMID 27088128.
Koselny, K; Green, J; DiDone, L; Halterman, JP; Fothergill, AW; Wiederhold, NP; Patterson, TF; Cushion, MT; Rappelye, C; Wellington, M; Krysan, DJ (2016). "The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis". Antimicrob Agents Chemother. 60 (12): 7115–7127. doi:10.1128/AAC.01061-16. PMC 5118990. PMID 27645246.
Koselny, K; Green, J; DiDone, L; Halterman, JP; Fothergill, AW; Wiederhold, NP; Patterson, TF; Cushion, MT; Rappelye, C; Wellington, M; Krysan, DJ (2016). "The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis". Antimicrob Agents Chemother. 60 (12): 7115–7127. doi:10.1128/AAC.01061-16. PMC 5118990. PMID 27645246.
Collier, MA; Peine, KJ; Gautum, S; Oghumu, S; Varikuti, S; Borteh, H; Papenfuss, TL; Satoskar, AR; Bachelder, EM; Ainslie, KM (Feb 29, 2016). "Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles". International Journal of Pharmaceutics. 499 (1–2): 186–94. doi:10.1016/j.ijpharm.2016.01.004. PMC 5730989. PMID 26768723.
Chiu, HC; Kulp, SK; Soni, S; Wang, D; Gunn, JS; Schlesinger, LS; Chen, CS (Dec 2009). "Eradication of intracellular Salmonella enterica serovar Typhimurium with a small-molecule, host cell-directed agent". Antimicrob Agents Chemother. 53 (12): 5236–5244. doi:10.1128/aac.00555-09. PMC 2786354. PMID 19805568.
Hoang, KV; Borteh, HM; Rajaram, MV; Peine, KJ; Curry, H; Collier, MA; Homsy, ML; Bachelder, EM; Gunn, JS; Schlesinger, LS; Ainslie, KM (Dec 2014). "Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection". Int J Pharm. 477 (1–2): 334–343. doi:10.1016/j.ijpharm.2014.10.022. PMC 4267924. PMID 25447826.
Chiu, HC; Soni, S; Kulp, SK; Curry, H; Wang, D; Gunn, JS; Schlesinger, LS; Chen, CS (Dec 2009). "Eradication of intracellular Francisella tularensis in THP-1 human macrophages with a novel autophagy inducing agent". J Biomed Sci. 16 (1): 110. doi:10.1186/1423-0127-16-110. PMC 2801672. PMID 20003180.
Hoang, KV; Curry, H; Collier, MA; Borteh, H; Bachelder, EM; Schlesinger, LS; Gunn, JS; Ainslie, KM (Mar 25, 2016). "Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge". Antimicrob Agents Chemother. 60 (4): 2052–62. doi:10.1128/AAC.02228-15. PMC 4808193. PMID 26787696.
Lo, JH; Kulp, SK; Chen, CS; Chiu, HC (Dec 2014). "Sensitization of intracellular Salmonella enterica serovar Typhimurium to aminoglycosides in vitro and in vivo by a host-targeted antimicrobial agent". Antimicrob Agents Chemother. 58 (12): 7375–82. doi:10.1128/AAC.03778-14. PMC 4249550. PMID 25267669.
Dent, Paul; et al. (2014). "GRP78 / BiP / HSPA5 / Dna K is a universal therapeutic target for human disease". Journal of Cellular Physiology. 230 (7): 1661–1676. doi:10.1002/jcp.24919. PMC 4402027. PMID 25546329.
Collier, MA; Gallovic, MD; Peine, KJ; Duong, AD; Bachelder, EM; Gunn, JS; Schlesingr, LS; Ainslie, KM (Nov 2013). "Delivery of host cell-directed therapeutics for intracellular pathogen clearance". Expert Rev Anti Infect Ther. 11 (11): 1225–1235. doi:10.1586/14787210.2013.845524. PMC 4070714. PMID 24134600.
Chiu, HC; Kulp, SK; Soni, S; Wang, D; Gunn, JS; Schlesinger, LS; Chen, CS (Dec 2009). "Eradication of intracellular Salmonella enterica serovar Typhimurium with a small-molecule, host cell-directed agent". Antimicrob Agents Chemother. 53 (12): 5236–5244. doi:10.1128/aac.00555-09. PMC 2786354. PMID 19805568.
Hoang, KV; Borteh, HM; Rajaram, MV; Peine, KJ; Curry, H; Collier, MA; Homsy, ML; Bachelder, EM; Gunn, JS; Schlesinger, LS; Ainslie, KM (Dec 2014). "Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection". Int J Pharm. 477 (1–2): 334–343. doi:10.1016/j.ijpharm.2014.10.022. PMC 4267924. PMID 25447826.
Hoang, KV; Borteh, HM; Rajaram, MV; Peine, KJ; Curry, H; Collier, MA; Homsy, ML; Bachelder, EM; Gunn, JS; Schlesinger, LS; Ainslie, KM (Dec 2014). "Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection". Int J Pharm. 477 (1–2): 334–343. doi:10.1016/j.ijpharm.2014.10.022. PMC 4267924. PMID 25447826.
Hoang, KV; Curry, H; Collier, MA; Borteh, H; Bachelder, EM; Schlesinger, LS; Gunn, JS; Ainslie, KM (Mar 25, 2016). "Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge". Antimicrob Agents Chemother. 60 (4): 2052–62. doi:10.1128/AAC.02228-15. PMC 4808193. PMID 26787696.

ncbi.nlm.nih.gov

Booth, L; Cruickshanks, N; Ridder, T; Chen, CS; Grant, S; Dent, P (Dec 2012). "OSU-03012 interacts with lapatinib to kill brain cancer cells". Cancer Biology and Therapy. 13 (14): 1501–11. doi:10.4161/cbt.22275. PMC 3542242. PMID 22990204.
Ma, Y; McCarty, SK; Kapuriya, NP; Brendel, VJ; Wang, C; Zhang, X; Jarjoura, D; Saji, M; Chen, CS; Ringel, MD (Aug 2013). "Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration". Journal of Clinical Endocrinology and Metabolism. 98 (8): E1314–22. doi:10.1210/jc.2012-3937. PMC 3733855. PMID 23709653.
Booth, L; Roberts, JL; Cruickshanks, N; Grant, S; Poklepovic, A; Dent, P (Oct 2014). "Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs". Molecular Cancer Therapeutics. 13 (10): 2384–98. doi:10.1158/1535-7163.MCT-14-0172. PMC 4185238. PMID 25103559.
Koselny, K; Green, J; Favazzo, L; Glazier, VE; DiDone, L; Ransford, S; Krysan, DJ (8 Apr 2016). "Antitumor/Antifungal Celecoxib Derivative AR-12 is a Non-Nucleoside Inhibitor of the ANL-Family Adenylating Enzyme Acetyl CoA Synthetase". ACS Infect Dis. 2 (4): 268–280. doi:10.1021/acsinfecdis.5b00134. PMC 4828684. PMID 27088128.
Koselny, K; Green, J; DiDone, L; Halterman, JP; Fothergill, AW; Wiederhold, NP; Patterson, TF; Cushion, MT; Rappelye, C; Wellington, M; Krysan, DJ (2016). "The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis". Antimicrob Agents Chemother. 60 (12): 7115–7127. doi:10.1128/AAC.01061-16. PMC 5118990. PMID 27645246.
Koselny, K; Green, J; DiDone, L; Halterman, JP; Fothergill, AW; Wiederhold, NP; Patterson, TF; Cushion, MT; Rappelye, C; Wellington, M; Krysan, DJ (2016). "The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis". Antimicrob Agents Chemother. 60 (12): 7115–7127. doi:10.1128/AAC.01061-16. PMC 5118990. PMID 27645246.
Collier, MA; Peine, KJ; Gautum, S; Oghumu, S; Varikuti, S; Borteh, H; Papenfuss, TL; Satoskar, AR; Bachelder, EM; Ainslie, KM (Feb 29, 2016). "Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles". International Journal of Pharmaceutics. 499 (1–2): 186–94. doi:10.1016/j.ijpharm.2016.01.004. PMC 5730989. PMID 26768723.
Chiu, HC; Kulp, SK; Soni, S; Wang, D; Gunn, JS; Schlesinger, LS; Chen, CS (Dec 2009). "Eradication of intracellular Salmonella enterica serovar Typhimurium with a small-molecule, host cell-directed agent". Antimicrob Agents Chemother. 53 (12): 5236–5244. doi:10.1128/aac.00555-09. PMC 2786354. PMID 19805568.
Hoang, KV; Borteh, HM; Rajaram, MV; Peine, KJ; Curry, H; Collier, MA; Homsy, ML; Bachelder, EM; Gunn, JS; Schlesinger, LS; Ainslie, KM (Dec 2014). "Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection". Int J Pharm. 477 (1–2): 334–343. doi:10.1016/j.ijpharm.2014.10.022. PMC 4267924. PMID 25447826.
Chiu, HC; Soni, S; Kulp, SK; Curry, H; Wang, D; Gunn, JS; Schlesinger, LS; Chen, CS (Dec 2009). "Eradication of intracellular Francisella tularensis in THP-1 human macrophages with a novel autophagy inducing agent". J Biomed Sci. 16 (1): 110. doi:10.1186/1423-0127-16-110. PMC 2801672. PMID 20003180.
Hoang, KV; Curry, H; Collier, MA; Borteh, H; Bachelder, EM; Schlesinger, LS; Gunn, JS; Ainslie, KM (Mar 25, 2016). "Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge". Antimicrob Agents Chemother. 60 (4): 2052–62. doi:10.1128/AAC.02228-15. PMC 4808193. PMID 26787696.
Lo, JH; Kulp, SK; Chen, CS; Chiu, HC (Dec 2014). "Sensitization of intracellular Salmonella enterica serovar Typhimurium to aminoglycosides in vitro and in vivo by a host-targeted antimicrobial agent". Antimicrob Agents Chemother. 58 (12): 7375–82. doi:10.1128/AAC.03778-14. PMC 4249550. PMID 25267669.
Dent, Paul; et al. (2014). "GRP78 / BiP / HSPA5 / Dna K is a universal therapeutic target for human disease". Journal of Cellular Physiology. 230 (7): 1661–1676. doi:10.1002/jcp.24919. PMC 4402027. PMID 25546329.
Collier, MA; Gallovic, MD; Peine, KJ; Duong, AD; Bachelder, EM; Gunn, JS; Schlesingr, LS; Ainslie, KM (Nov 2013). "Delivery of host cell-directed therapeutics for intracellular pathogen clearance". Expert Rev Anti Infect Ther. 11 (11): 1225–1235. doi:10.1586/14787210.2013.845524. PMC 4070714. PMID 24134600.
Chiu, HC; Kulp, SK; Soni, S; Wang, D; Gunn, JS; Schlesinger, LS; Chen, CS (Dec 2009). "Eradication of intracellular Salmonella enterica serovar Typhimurium with a small-molecule, host cell-directed agent". Antimicrob Agents Chemother. 53 (12): 5236–5244. doi:10.1128/aac.00555-09. PMC 2786354. PMID 19805568.
Hoang, KV; Borteh, HM; Rajaram, MV; Peine, KJ; Curry, H; Collier, MA; Homsy, ML; Bachelder, EM; Gunn, JS; Schlesinger, LS; Ainslie, KM (Dec 2014). "Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection". Int J Pharm. 477 (1–2): 334–343. doi:10.1016/j.ijpharm.2014.10.022. PMC 4267924. PMID 25447826.
Hoang, KV; Borteh, HM; Rajaram, MV; Peine, KJ; Curry, H; Collier, MA; Homsy, ML; Bachelder, EM; Gunn, JS; Schlesinger, LS; Ainslie, KM (Dec 2014). "Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection". Int J Pharm. 477 (1–2): 334–343. doi:10.1016/j.ijpharm.2014.10.022. PMC 4267924. PMID 25447826.
Hoang, KV; Curry, H; Collier, MA; Borteh, H; Bachelder, EM; Schlesinger, LS; Gunn, JS; Ainslie, KM (Mar 25, 2016). "Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge". Antimicrob Agents Chemother. 60 (4): 2052–62. doi:10.1128/AAC.02228-15. PMC 4808193. PMID 26787696.

reuters.com

Arno Therapeutics Inc receives European orphan drug designation for OSU-03012 to treat two infectious diseases. Reuters, 30 Apr 2015.

semanticscholar.org

api.semanticscholar.org

Liu, J; Qin, CK; Lv, W; Zhao, Q; Qin, CY (2013). "OSU-03012, a non-Cox inhibiting celecoxib derivative, induces apoptosis of human esophageal carcinoma cells through a p53/Bax/cytochrome c/caspase-9-dependent pathway" (PDF). Anticancer Drugs. 24 (7): 690–8. doi:10.1097/CAD.0b013e328362469f. PMID 23652278. S2CID 6028415. Archived from the original (PDF) on 2019-03-08.

pdfs.semanticscholar.org

Liu, J; Qin, CK; Lv, W; Zhao, Q; Qin, CY (2013). "OSU-03012, a non-Cox inhibiting celecoxib derivative, induces apoptosis of human esophageal carcinoma cells through a p53/Bax/cytochrome c/caspase-9-dependent pathway" (PDF). Anticancer Drugs. 24 (7): 690–8. doi:10.1097/CAD.0b013e328362469f. PMID 23652278. S2CID 6028415. Archived from the original (PDF) on 2019-03-08.

web.archive.org

Liu, J; Qin, CK; Lv, W; Zhao, Q; Qin, CY (2013). "OSU-03012, a non-Cox inhibiting celecoxib derivative, induces apoptosis of human esophageal carcinoma cells through a p53/Bax/cytochrome c/caspase-9-dependent pathway" (PDF). Anticancer Drugs. 24 (7): 690–8. doi:10.1097/CAD.0b013e328362469f. PMID 23652278. S2CID 6028415. Archived from the original (PDF) on 2019-03-08.